Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update announces a Phase 1/2 study of HB0043 for adults with moderate to severe acne vulgaris, with the trial currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• HB0043

Snippet

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. | Conditions: Acne Vulgaris | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING